Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study-Reference-Cited by-同舟云学术

Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study

Published:2024-06-01 Issue:6 Volume:31 Page:864-875
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Takeshita Mitsuhide¹,Tanaka Atsushi¹,Yoshida Hisako²,Nakamura Ikuko³,Shibata Yoshisato⁴,Hata Shiro⁵,Kushiyama Akifumi⁶,Okutsu Masaaki⁷,Ishizu Tomoko⁸,Node Koichi¹

Affiliation:

1. Department of Cardiovascular Medicine, Saga University

2. Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine

3. Department of Cardiovascular Medicine, Saga-Ken Medical Centre Koseikan

4. Department of Cardiology, Miyazaki Medical Association Hospital

5. Department of Cardiology, Sasebo City General Hospital

6. Department of Pharmacotherapy, Meiji Pharmaceutical University

7. Department of Cardiovascular Medicine, New Tokyo Hospital

8. Department of Cardiology, Faculty of Medicine, University of Tsukuba

Publisher

Japan Atherosclerosis Society

Link

https://www.jstage.jst.go.jp/article/jat/31/6/31_64574/_pdf

Reference33 articles.

1. 1) Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med, 1999; 340: 115-126

2. 2) Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol, 2005; 16: 3553-3562

3. 3) Yu MA, Sanchez-Lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens, 2010; 28: 1234-1242

4. 4) Mizuno Y, Yamamotoya T, Nakatsu Y, Ueda K, Matsunaga Y, Inoue MK, Sakoda H, Fujishiro M, Ono H, Kikuchi T, Takahashi M, Morii K, Sasaki K, Masaki T, Asano T, and Kushiyama A. Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice. Int J Mol Sci, 2019; 20

5. 5) Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol, 2004; 44: 1945-1956

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leucocyte Count: Inflammatory and ROS Biomarkers of ASCVD;Journal of Atherosclerosis and Thrombosis;2024-06-01